The designation LOC646762 inhibitors likely refers to a specific class of chemical inhibitors designed to bind to and inhibit an entity known as LOC646762. This entity, presumably a protein or enzyme, is involved in a particular cellular process. The inhibitors are characterized by their ability to specifically interact with the LOC646762 molecule and impede its normal function. This is achieved by binding to the active site or another critical domain of the target molecule, preventing it from performing its role in the cellular process. The development of such inhibitors involves an intricate understanding of the molecular structure of LOC646762, as well as the pathways in which it functions.
The discovery and fine-tuning of LOC646762 inhibitors necessitate a multidisciplinary approach. Structural biologists might employ techniques such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy to obtain high-resolution images of the target in its native environment. This structural information is crucial as it enables the identification of potential binding sites that are amenable to inhibition. Medicinal chemists, alongside computational biologists, often use this data to model interactions between LOC646762 and potential inhibitory compounds. These models help in the design of molecules that can interact with high specificity and potency. The process is iterative, with initial inhibitor designs being synthesized and assessed for their ability to bind to LOC646762, followed by successive rounds of optimization. This optimization focuses on enhancing the molecular interactions between the inhibitor and LOC646762, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, to increase the likelihood of successful inhibition. The ultimate goal is to develop inhibitors that can reliably and effectively bind to the LOC646762 molecule with minimal interaction with other biological molecules, thus ensuring specificity and reducing the potential for undesired effects.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, which could result in decreased transcription of genes. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Aphidicolin blocks DNA polymerase, which is essential for DNA replication and could indirectly affect gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage and potentially reducing transcription levels. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates into DNA and interferes with the function of topoisomerase II, which can reduce transcription. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide stabilizes the DNA-topoisomerase II complex, preventing the religation step of the DNA breakage-resealing reaction, which could inhibit transcription. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Flavopiridol inhibits cyclin-dependent kinases, which are important for cell cycle progression and thus can impact transcription regulation. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, necessary for guanine synthesis, which can result in reduced RNA and DNA synthesis. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglamide has been shown to inhibit translation initiation, leading to a decrease in protein synthesis. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $266.00 $5100.00 $39576.00 $690.00 | 4 | |
Sinefungin is a nucleoside antibiotic that can inhibit S-adenosyl-L-methionine-dependent methyltransferases, potentially affecting gene expression. | ||||||
Streptozotocin (U-9889) | 18883-66-4 | sc-200719 sc-200719A | 1 g 5 g | $110.00 $510.00 | 152 | |
Streptozotocin causes alkylation of DNA, which can lead to reduced DNA replication and transcription. | ||||||